Sign in

CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
011441223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$64,039
in 7 filings, $7K under 10b5-1 plans

Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
  2. Swanton Robert Charles −$12K Director sold 18% of stake
  3. Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
  4. Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
  5. Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Date Insider Transaction Shares Price Value Owned after
2019-05-28 SVLSF V, LLC 10% owner Conversion +623,196 1,497,905
2019-05-28 SVLSF V, LLC 10% owner Conversion +18,485 18,485
2019-05-28 SVLSF V, LLC 10% owner Conversion +13,169 31,654
2019-05-28 SVLSF V, LLC 10% owner Purchase +377,732 $14.00 $5.3M 1,875,637
2019-05-28 SVLSF V, LLC 10% owner Purchase +7,983 $14.00 $112K 39,637
2019-05-28 SVLSF V, LLC 10% owner Conversion · Series A Preferred Shares −874,709 0
2019-05-28 SVLSF V, LLC 10% owner Conversion · Series B1 Preferred Shares −623,196 0
2019-05-28 SVLSF V, LLC 10% owner Conversion · Series A Preferred Shares −18,485 0
2019-05-28 SVLSF V, LLC 10% owner Conversion · Series B1 Preferred Shares −13,169 0
2019-05-28 Anstey Michael Director Conversion +1,081,823 1,081,823
2019-05-28 Anstey Michael Director Option exercise +125,587 1,207,410
2019-05-28 Anstey Michael Director Conversion +229,741 1,437,151
2019-05-28 Anstey Michael Director Purchase +314,286 $14.00 $4.4M 1,751,437
2019-05-28 Anstey Michael Director Conversion · Series B1 Preferred Shares +1,081,823 0
2019-05-28 Anstey Michael Director Option exercise · Series B1 Preferred Shares Warrants +125,587 0
2019-05-28 Anstey Michael Director Conversion · Series B2 Preferred Shares +229,741 0
2019-05-28 BINGHAM KATE Director Conversion +874,709 874,709
2019-05-28 BINGHAM KATE Director Conversion +623,196 1,497,905
2019-05-28 BINGHAM KATE Director Conversion +18,485 18,485
2019-05-28 BINGHAM KATE Director Conversion +13,169 31,654

Page 32 of 34 · 664 trades